(IN BRIEF) Evonik is investing more than CAD 150 million, or approximately EUR 93 million, in a new GMP drug product manufacturing facility for lipid-based drug delivery in Vancouver, Canada, supported by up to CAD 68 million, or around EUR … Read the full press release
Posted in Business, Chemicals, Germany, Government, Healthcare, Industrial, Investment, Pharma & Biotech, Science, Technology
Tagged 2034, adjuvant supply, advanced medicines, biotech ecosystem, Birmingham Alabama, British Columbia, CAD 150 million, CAD 68 million, Cambridge Innovation Satellite, CANADA, Canada Economic Development for Quebec Regions, Canadian federal government, CDMO services, clinical manufacturing, commercial process scale-up, commercial scale, Custom Solutions, Dossenheim, drug product manufacturing, end of 2029 production, equipment engineering, EUR 42 million, EUR 93 million, Evonik, Evonik Expands Lipid-Based Drug Delivery Capacity With New Vancouver GMP Facility, Evonik Health Care, Evonik Invests CAD 150 Million in Vancouver LNP Manufacturing Expansion, Evonik Vancouver Laboratories, formulation development, formulation research, Germany, GMP manufacturing facility, good manufacturing practice, Greater Boston, Greater Vancouver, Guido Skudlarek, Hanau, highly skilled jobs, Lafayette Indiana, Lauren Kjeldsen, life sciences innovation, lipid chemistry, lipid nanoparticles, lipid-based drug delivery, liposomal delivery systems, LNP, Mélanie Joly, microbiological testing, mRNA, New Evonik GMP Facility to Support Lipid Nanoparticle Drug Development and Manufacturing, Northern Lipids, nucleic acid therapeutics, parenteral drugs, pharmaceutical manufacturing, process engineering, QC, quality control, regulatory know-how, sterile manufacturing, Strategic Response Fund, therapeutics, Tippecanoe Labs, Transferra Nanosciences, University of British Columbia, USD 2.7 billion market forecast, vaccines, Vancouver
(IN BRIEF) Evonik has partnered with Zurich-based evitria to offer the eviCHO Expression Kit, a ready-to-use transient protein expression kit based on CHO cells for biopharmaceutical research and development. The kit is designed to simplify workflows, reduce troubleshooting and support … Read the full press release
Posted in Business, Chemicals, Germany, Healthcare, Pharma & Biotech, Science, Switzerland, Technology
Tagged Advance Precision Biosolutions, amino acids, antibodies, antibody expression, antibody-based molecules, Atlas Antibodies group, biologics development, biomanufacturing, biopharma customers, biopharmaceutical research, chemically defined ingredients, Chinese Hamster Ovary cells, CHO cells, CHO-K1 cells, dipeptides, eviCHO Expression Kit, eviCHO Expression Kit Aims to Simplify Transient Protein Production for Biopharma Research, evitria, Evonik, Evonik and evitria Launch Ready-to-Use CHO-Based Protein Expression Kit, Evonik Expands Precision Biosolutions Portfolio Through evitria Partnership, Guido Skudlarek, InVitria, lipids, non-animal-derived ingredients, protein production, recombinant human serum albumin, rHSA, Stefan Schmidt, surfactants, Switzerland, transient protein expression, Zurich
(IN BRIEF) Evonik is selling selected production assets for pharmaceutical ingredients at its Hanau site in Germany to the ProChem Group, with the transaction expected to close on 19 June 2026. The divestment supports Evonik Health Care’s strategy of streamlining … Read the full press release
Posted in Business, Chemicals, European Union, France, Germany, Healthcare, Industrial, Pharma & Biotech, Science, Technology
Tagged active pharmaceutical ingredients, advanced pharmaceutical lipids, amino acids, analytical testing, APIs, asset streamlining, CDMO services, cell-culture ingredients, contract manufacturing, cosmetics ingredients, distillation, Dr Jürgen Krauter, drug delivery technologies, drying, Essen, Evonik, Evonik Advances Health Care Growth Strategy Through Hanau Production Asset Transfer, Evonik Health Care, Evonik Sells Hanau Pharmaceutical Ingredient Production Assets to ProChem Group, Evonik Streamlines Health Care Footprint with Sale of Selected Hanau Assets to ProChem, extraction, food additives, France, gene delivery, Gerhard Jakobi, Germany, GMP facility, GMP-compliant production, grinding, Guido Skudlarek, Ham, Hanau, healthcare portfolio, injectable drug delivery, Intermediates, Janusz Berger, Jochen Pohl, Jörg Blumhoff, Kerstin Oberhaus, keto acids, mixing, mRNA delivery, oral drug delivery, packaging, pharmaceutical customers, pharmaceutical ingredients, pharmaceutical lipids, pharmaceutical-grade products, precision biosolutions, ProChem Acquires Evonik GMP Production Facilities for Pharmaceutical Ingredients in Hanau, ProChem GmbH, ProChem Group, ProChem InnoTec GmbH, production assets, regulatory-compliant solutions, REXIM, RNA therapeutics, sieving, specialty chemicals, synthesis, Thomas Hermann, Wuming
(IN BRIEF) Evonik and Higuchi Inc. have launched a new joint laboratory in Yokohama, Japan, to advance oral drug delivery innovation and support pharmaceutical companies with localized technical expertise. The Open Pharma Lab will provide access to Evonik’s EUDRAGIT® polymers … Read the full press release
Posted in Business, Chemicals, Germany, Industrial, Investment, Management, Pharma & Biotech
Tagged Asia market, biotechnology, drug delivery, EUDRAGIT® Polymers, Evonik expands Asia innovation network with new Yokohama lab in partnership with Higuchi, Evonik Industries, excipients, formulation development, Guido Skudlarek, Healthcare, Higuchi Inc, Open Pharma Lab, pharmaceutical innovation, Wataru Ohama, Yokohama Japan
(IN BRIEF) Evonik has commenced a major expansion at its Charleston site in Berkeley County, South Carolina, aimed at increasing the production capacity of precipitated silica by 50% to meet rising demand from the tire industry, especially for green tires. … Read the full press release
Posted in Business, Chemicals, Environment, Financial, Germany, Government, Industrial, Infrastructure & Utilities, Investment, Management, News, Technology
Tagged Charleston Facility, Evonik, expansion, Guido Skudlarek, Johnny Cribb, Kenneth Bittner, Lauren Kjeldsen, partnership, silica, sustainability
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?